These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6487483)

  • 1. Theophylline-rifampicin interaction: non-selective induction of theophylline metabolic pathways.
    Robson RA; Miners JO; Wing LM; Birkett DJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):445-8. PubMed ID: 6487483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking and theophylline clearance and metabolism.
    Grygiel JJ; Birkett DJ
    Clin Pharmacol Ther; 1981 Oct; 30(4):491-6. PubMed ID: 7285483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction.
    Birkett DJ; Miners JO; Attwood J
    Br J Clin Pharmacol; 1983 May; 15(5):567-9. PubMed ID: 6860533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity and dose-dependency of the inhibitory effect of propranolol on theophylline metabolism in man.
    Miners JO; Wing LM; Lillywhite KJ; Robson RA
    Br J Clin Pharmacol; 1985 Sep; 20(3):219-23. PubMed ID: 4041342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of ofloxacin and enoxacin on the metabolic pathways of theophylline in healthy volunteers. A pilot study.
    Wijnands WJ; Janssen TJ; Guelen PJ; Vree TB; De Witte TM
    Pharm Weekbl Sci; 1988 Dec; 10(6):272-6. PubMed ID: 3211700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential induction of antipyrine metabolism by rifampicin.
    Toverud EL; Boobis AR; Brodie MJ; Murray S; Bennett PN; Whitmarsh V; Davies DS
    Eur J Clin Pharmacol; 1981; 21(2):155-60. PubMed ID: 7341283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rifampicin administration on theophylline pharmacokinetics in humans.
    Powell-Jackson PR; Jamieson AP; Gray BJ; Moxham J; Williams R
    Am Rev Respir Dis; 1985 Jun; 131(6):939-40. PubMed ID: 4003946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of rifampicin-induced theophylline metabolism by diltiazem/rifampicin coadministration in healthy volunteers.
    Adebayo GI; Akintonwa A; Mabadeje AF
    Eur J Clin Pharmacol; 1989; 37(2):127-31. PubMed ID: 2792166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age on patterns of theophylline metabolism.
    Grygiel JJ; Birkett DJ
    Clin Pharmacol Ther; 1980 Oct; 28(4):456-62. PubMed ID: 7408405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6.
    Dilger K; Greiner B; Fromm MF; Hofmann U; Kroemer HK; Eichelbaum M
    Pharmacogenetics; 1999 Oct; 9(5):551-9. PubMed ID: 10591535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of propranolol metabolism by rifampicin.
    Herman RJ; Nakamura K; Wilkinson GR; Wood AJ
    Br J Clin Pharmacol; 1983 Nov; 16(5):565-9. PubMed ID: 6639842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis.
    Teunissen MW; Bakker W; Meerburg-Van der Torren JE; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):701-6. PubMed ID: 6508979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic drug interactions with theophylline.
    Jonkman JH; Upton RA
    Clin Pharmacokinet; 1984; 9(4):309-34. PubMed ID: 6147220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism.
    Dahlqvist R; Bertilsson L; Birkett DJ; Eichelbaum M; Säwe J; Sjöqvist F
    Clin Pharmacol Ther; 1984 Jun; 35(6):815-21. PubMed ID: 6734034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of theophylline and theobromine metabolism in man.
    Birkett DJ; Dahlqvist R; Miners JO; Lelo A; Billing B
    Drug Metab Dispos; 1985; 13(6):725-8. PubMed ID: 2867879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR; Egan JM; Dickinson TH; Carrum G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
    Campbell ME; Grant DM; Inaba T; Kalow W
    Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-drug interactions affecting fluoroquinolones.
    Wijnands GJ; Vree TB; Janssen TJ; Guelen PJ
    Am J Med; 1989 Dec; 87(6C):47S-51S. PubMed ID: 2603893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rifampin on theophylline disposition.
    Straughn AB; Henderson RP; Lieberman PL; Self TH
    Ther Drug Monit; 1984; 6(2):153-6. PubMed ID: 6740733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.